3-Chloro-5,6-dihydro-5,6-di(3-dimethylamino)propionyldibenzo[b,f][1,4,5]thiadiazepine

ID: ALA3265401

Chembl Id: CHEMBL3265401

PubChem CID: 46219783

Max Phase: Preclinical

Molecular Formula: C22H27ClN4O2S

Molecular Weight: 447.00

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)CCC(=O)n1c2ccccc2sc2ccc(Cl)cc2n1C(=O)CCN(C)C

Standard InChI:  InChI=1S/C22H27ClN4O2S/c1-24(2)13-11-21(28)26-17-7-5-6-8-19(17)30-20-10-9-16(23)15-18(20)27(26)22(29)12-14-25(3)4/h5-10,15H,11-14H2,1-4H3

Standard InChI Key:  POZAFCASJJUQGZ-UHFFFAOYSA-N

Associated Targets(Human)

SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ACHE Acetylcholinesterase (1035 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.00Molecular Weight (Monoisotopic): 446.1543AlogP: 4.62#Rotatable Bonds: 6
Polar Surface Area: 50.48Molecular Species: BASEHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.02CX LogP: 3.33CX LogD: 0.66
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.55Np Likeness Score: -1.04

References

1. González-Muñoz GC, Arce MP, Pérez C, Romero A, Villarroya M, López MG, Conde S, Rodríguez-Franco MI..  (2014)  Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases.,  81  [PMID:24858540] [10.1016/j.ejmech.2014.04.075]

Source